Very recently, in advanced cervical cancer, the use of the humanized anti-VEGF monoclonal antibody bevacizumab, in combination with chemotherapy, showed and improvement in patients’ overall survival [18]. The gene discussed is VEGFA; the disease is cervical cancer.